Eocene (EOCN) vs Genprex (GNPX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Genprex is the larger company by market cap ($1.9 million vs $1.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EOCN | GNPX |
|---|---|---|
| Share price | $1.78 | $1.45 |
| Market cap | $1.90M | $1.94M |
| 1-day change | +1.73% | -13.17% |
| P/E ratio (TTM) | — | 0.01 |
| EPS (TTM) | $-15.21 | $98.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-10.31M | $-16.23M |
| 52-week high | $10.08 | $80.96 |
| 52-week low | $1.75 | $1.45 |
| Distance from 52-week high | -82.34% | -98.21% |
| Analyst consensus | none | — |
| Average volume | 18.17K | 168.88K |
| Shares outstanding | 1.07M | 1.33M |
| Employees | 3 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Eocene
EOCN stock →Eocene Ltd. a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases and related indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
EOCN vs GNPX FAQ
Which is bigger, Eocene or Genprex?
Genprex (GNPX) is larger, with a market capitalization of $1.94M compared with $1.90M for Eocene (EOCN).
Are Eocene and Genprex in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.